Pneumococcal vaccine to counter emerging infectious disease threat in the military.

Journal Article (Journal Article)

Streptococcus pneumoniae causes severe morbidity and mortality worldwide and poses a significant threat to the health and readiness of U.S. military personnel. Although a vaccine to prevent pneumococcal infections has been available for almost 25 years, its use has been limited. Recently, increasing antibiotic resistance among S. pneumoniae strains has emerged, prompting health care professionals to reevaluate the benefit of administering pneumococcal vaccine. The Naval Health Research Center, in collaboration with professionals from numerous civilian and military organizations, has initiated a rigorous double-blind, placebo-controlled trial investigating the operational value of vaccinating young adults as they enlist in the military.

Full Text

Duke Authors

Cited Authors

  • McKeehan, JA; Ryan, MA; Gray, GC; Pneumococcal Vaccine Study Team,

Published Date

  • December 2001

Published In

Volume / Issue

  • 166 / 12

Start / End Page

  • 1087 - 1090

PubMed ID

  • 11778410

International Standard Serial Number (ISSN)

  • 0026-4075


  • eng

Conference Location

  • England